Surgery Partners, Inc. (SGRY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 1.5B 3B 4.5B FY13: 284.6M FY14: 403.3M FY15: 959.9M FY16: 1.1B FY18: 1.8B FY19: 1.8B FY20: 1.9B FY21: 2.2B FY22: 2.5B FY23: 2.7B FY24: 3.1B FY25: 3.3B FY14 FY16 FY19 FY21 FY23 FY25

Gross Profit Annual

0 300M 600M 900M FY18: 410.1M FY19: 423.8M FY20: 379.8M FY21: 491.4M FY22: 574.9M FY23: 647.5M FY24: 745.6M FY25: 765M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

0 150M 300M 450M FY13: 58.2M FY14: 50.8M FY15: 144.8M FY16: 196.5M FY18: 77.8M FY19: 235.9M FY20: 183M FY21: 302.2M FY22: 345.2M FY23: 328M FY24: 348.8M FY25: 389.5M FY14 FY16 FY19 FY21 FY23 FY25

Net Income Annual

-210M -140M -70M 0 70M 140M 210M FY13: -9.1M FY14: -65.9M FY15: 1.4M FY16: 9.5M FY18: -205.7M FY19: -74.8M FY20: -116.1M FY21: -70.9M FY22: -54.6M FY23: -11.9M FY24: -168.1M FY25: -77.9M FY14 FY16 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 900M 1.8B 2.7B FY13: 169.8M FY14: 254.2M FY15: 669.3M FY16: 821.2M FY18: 1.4B FY19: 1.4B FY20: 1.5B FY21: 1.7B FY22: 2B FY23: 2.1B FY24: 2.4B FY25: 2.5B FY14 FY16 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 150M 300M 450M FY13: 49.1M FY14: 21.9M FY15: 84.5M FY16: 125.2M FY18: 144.6M FY19: 129.5M FY20: 246.9M FY21: 87.1M FY22: 158.8M FY23: 293.8M FY24: 300.1M FY25: 274.3M FY14 FY16 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 80M 160M 240M FY13: 44.9M FY14: 14.2M FY15: 51M FY16: 86.1M FY18: 104.8M FY19: 55.9M FY20: 204M FY21: 29.5M FY22: 78.2M FY23: 205M FY24: 209.7M FY25: 195.6M FY14 FY16 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 50M 100M 150M FY13: 31.8M FY14: 32.3M FY15: 37.5M FY16: 48.2M FY18: 48M FY19: 48.3M FY20: 48.8M FY21: 72.4M FY22: 92M FY23: 125.6M FY24: 126.1M FY25: 127.2M FY14 FY16 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q4 '14: -2.06 Q1 '15: -2.14 Q2 '15: -2.29 Q3 '15: -2.17 Q4 '15: -0.13 Q1 '16: -0.07 Q2 '16: 0.14 Q3 '16: 0.19 Q4 '16: 0.19 Q1 '17: 0.28 Q2 '17: 0.15 Q3 '18: -2.54 Q4 '18: -4.96 Q1 '19: -5.03 Q2 '19: -5.05 Q3 '19: -4.95 Q4 '19: -2.29 Q1 '20: -2.45 Q2 '20: -2.72 Q3 '20: -3.67 Q4 '20: -3.18 Q1 '21: -2.99 Q2 '21: -2.52 Q3 '21: -1.34 Q4 '21: -1.12 Q1 '22: -0.41 Q2 '22: -0.23 Q3 '22: -0.23 Q4 '22: -0.59 Q1 '23: -0.93 Q2 '23: -0.57 Q3 '23: -0.33 Q4 '23: -0.09 Q1 '24: 0.01 Q2 '24: -0.26 Q3 '24: -0.47 Q4 '24: -1.33 Q1 '25: -1.53 Q2 '25: -1.43 Q3 '25: -1.36 Q4 '25: -0.61 Q1 '26: -0.59 Q2 '26: -0.69 Q4 '14 Q2 '16 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.